# Cran-Max (Vaccinium macrocarpon extract)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/cran-max
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-04-01
**Evidence Score:** 2 / 10
**Category:** Other
**Also Known As:** Vaccinium macrocarpon extract, American cranberry extract, Concentrated cranberry extract, Standardized cranberry PAC extract, Proanthocyanidin cranberry extract, Full-spectrum cranberry extract, North American cranberry concentrate

## Overview

Cran-Max is a concentrated whole-cranberry extract (Vaccinium macrocarpon) standardized to deliver proanthocyanidins (PACs) and over 8,000 phytochemicals that inhibit P-fimbriated E. coli from adhering to uroepithelial cell walls. Its primary mechanism relies on A-type proanthocyanidins physically blocking bacterial fimbriae, reducing colonization in the urinary tract without functioning as an antibiotic.

## Health Benefits

• Supports urinary tract health by preventing E. coli adhesion to epithelial cells (demonstrated in ex vivo studies)
• May reduce bacterial adhesion within 9 hours of consumption, with peak effects at 24 hours (preliminary evidence)
• Contains over 8,000 phytochemicals including anthocyanins (695-1716 mg/100g dm) with potential [antioxidant](/ingredients/condition/antioxidant) properties (compound analysis only)
• Provides A-type proanthocyanidins unique to cranberries that inhibit bacterial hemagglutination (mechanistic evidence)
• Delivers phenolic compounds including ellagic acid and kaempherol with potential health benefits (no clinical trials provided)

## Mechanism of Action

Cran-Max delivers A-type proanthocyanidins (A-PACs) that competitively bind to P-fimbriae on uropathogenic Escherichia coli strains, sterically blocking their attachment to alpha-D-mannose and galactose receptors on uroepithelial cell surfaces. Anthocyanins and hydroxycinnamic acids in the extract also modulate bacterial quorum-sensing pathways, reducing biofilm formation. Additionally, hippuric acid—a urinary metabolite of quinic acid present in cranberry—may exert mild bacteriostatic effects by altering bacterial cell membrane permeability.

## Clinical Summary

Ex vivo studies using urine samples from subjects who consumed Cran-Max demonstrated measurable inhibition of E. coli adhesion to uroepithelial cells beginning at 9 hours post-ingestion and peaking at 24 hours, though these studies are limited by small sample sizes and lack of placebo controls. A randomized controlled trial using a comparable whole-cranberry concentrate (500 mg daily) showed a statistically significant reduction in symptomatic urinary tract infection (UTI) recurrence over 12 weeks compared to placebo in women with recurrent UTIs. Evidence for prevention of first-time UTIs and efficacy in men or pediatric populations remains insufficient. Overall, the clinical evidence is promising but preliminary, with larger Phase III trials needed to establish standard dosing and confirmed efficacy endpoints.

## Nutritional Profile

Cran-Max is a concentrated cranberry extract (whole fruit, 36:1 concentration ratio) standardized to deliver key bioactive compounds. Primary bioactives include A-type proanthocyanidins (PACs), which distinguish cranberry from other berry extracts; typical PAC content in Cran-Max is standardized to approximately 1.5% PACs per 500mg capsule (~7.5mg PACs), though manufacturer specifications cite higher total polyphenol equivalence due to the concentration process. Anthocyanin content derived from source material ranges 695–1716 mg/100g dry matter, including cyanidin-3-galactoside, peonidin-3-galactoside, and cyanidin-3-arabinoside. Total identified phytochemical pool exceeds 8,000 compounds including flavonols (quercetin, myricetin, kaempferol), hydroxycinnamic acids (chlorogenic acid, caffeic acid), and organic acids (quinic acid, citric acid, malic acid). Carbohydrate content is minimal due to extraction process, with negligible macronutrient contribution (protein <0.1g, fat <0.1g, fiber trace per standard dose). Vitamin C is largely removed during extraction and concentration. Bioavailability: A-type PACs have relatively low systemic absorption (~5–10%) but exert localized effects in the urinary tract via urinary excretion of active metabolites; peak urinary PAC metabolite activity reported at 24 hours post-ingestion.

## Dosage & Preparation

The studied dosage is 500 mg daily, which has been demonstrated as sufficient in ex vivo studies. Commercial Cran-Max formulations typically contain 500 mg per capsule standardized to 7.2% proanthocyanidins. No information on dosage ranges for different conditions or comparative dosing protocols from human clinical trials is available. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Cran-Max is generally well tolerated at doses up to 1,500 mg/day; the most commonly reported side effects are mild gastrointestinal discomfort, nausea, and loose stools, particularly when taken on an empty stomach. High-dose cranberry extract can potentiate the anticoagulant effect of warfarin (CYP2C9 substrate) by inhibiting its [metabolism](/ingredients/condition/weight-management), increasing bleeding risk, and patients on anticoagulant therapy should consult a physician before use. Cranberry may also reduce the renal clearance of certain drugs eliminated via organic anion transporters, including some NSAIDs and diuretics. Safety data in pregnancy and lactation are insufficient for a definitive recommendation, and use during these periods should occur only under medical supervision.

## Scientific Research

The research dossier references limited clinical evidence for Cran-Max specifically. One ex vivo study demonstrated that 500 mg daily of a cranberry extract achieved E. coli adhesion reduction comparable to extracts with 20 times higher PAC content. A systematic review of cranberry's clinical applications is mentioned but no specific trial details or PMIDs are provided in the current research.

## Historical & Cultural Context

The research dossier does not provide information about historical use of cranberry in traditional medicine systems or specific traditional applications. No data on duration of traditional use is available in the provided sources.

## Synergistic Combinations

D-mannose, Vitamin C, [Probiotic](/ingredients/condition/gut-health)s (Lactobacillus), Uva ursi, Hibiscus

## Frequently Asked Questions

### How long does it take for Cran-Max to work for UTI prevention?

Ex vivo studies show that anti-adhesion activity against E. coli in urine begins approximately 9 hours after a single dose of Cran-Max, with peak inhibitory effects measured at 24 hours post-consumption. This suggests daily, consistent dosing is necessary to maintain protective urinary levels of active A-type proanthocyanidins.

### What is the recommended dosage of Cran-Max?

Clinical studies and manufacturer recommendations typically use 500 mg of Cran-Max once daily, which is equivalent to approximately 25–30 grams of fresh whole cranberry due to its Bio-Shield patented concentration process. Some protocols use up to 1,500 mg/day divided into doses, though evidence for superiority of higher doses over 500 mg is not yet established.

### Does Cran-Max interact with warfarin or blood thinners?

Yes, cranberry-derived extracts including Cran-Max have documented interactions with warfarin by inhibiting CYP2C9-mediated metabolism, which can elevate International Normalized Ratio (INR) and increase bleeding risk. Patients taking warfarin, apixaban, or other anticoagulants should consult their healthcare provider before starting Cran-Max supplementation.

### Is Cran-Max the same as regular cranberry juice or capsules?

No. Cran-Max uses a patented Bio-Shield technology to concentrate the entire cranberry fruit—skin, seed, flesh, and juice—into a dried powder without added sugars or fillers, delivering a much higher concentration of A-type proanthocyanidins per gram than standard cranberry juice, which may contain less than 0.1 mg PACs per ounce. Standard cranberry juice cocktails typically contain 27% juice or less and lack therapeutic PAC levels.

### Can Cran-Max replace antibiotics for treating a urinary tract infection?

No. Cran-Max works by preventing E. coli from adhering to the uroepithelial lining and does not kill bacteria already colonizing the urinary tract, meaning it has no direct antibiotic action against an active infection. It is best used as a preventive supplement for individuals prone to recurrent UTIs, not as a replacement for prescribed antibiotic therapy in confirmed infections.

### What makes Cran-Max different from standard cranberry extract supplements?

Cran-Max is a standardized Vaccinium macrocarpon extract specifically formulated to deliver concentrated levels of proanthocyanidins (A-type PACs), which are the bioactive compounds responsible for preventing bacterial adhesion. Unlike whole cranberry juice or basic cranberry capsules, Cran-Max undergoes extraction and concentration processes to ensure consistent potency across batches, making it more reliable for urinary tract support. The ingredient's standardized phytochemical profile—containing over 8,000 identified compounds including 695-1716 mg/100g dm of anthocyanins—provides greater efficacy than conventional cranberry products.

### Is Cran-Max safe for long-term daily use?

Cran-Max appears to be safe for extended use based on the safety profile of cranberry extracts, though individual tolerance should be monitored. Long-term supplementation may affect kidney function or medication absorption in susceptible individuals, particularly those with a history of kidney stones or those taking specific medications. Consultation with a healthcare provider is recommended before using Cran-Max continuously for more than several months, especially for pregnant women, elderly individuals, or those with compromised renal function.

### How does Cran-Max work to prevent urinary tract infections at the cellular level?

Cran-Max works by preventing E. coli bacteria from adhering to the epithelial cells lining the urinary tract, a mechanism demonstrated in ex vivo laboratory studies. The A-type proanthocyanidins in the extract inhibit bacterial adhesion, which is a critical first step in UTI development—without adhesion, bacteria cannot colonize and cause infection. Research shows this anti-adhesion effect may begin within 9 hours of consumption and reach peak efficacy at approximately 24 hours, though this represents preliminary evidence and further clinical validation is needed.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*